a public good project by the
Synthesis
Company
of California

© 2026

Anneke Geurts‐Moespot | doi.page

0 works0 citations0 h-index

Anneke Geurts‐Moespot

Radboud University Nijmegen(NL)Radboud University Medical Center(NL)

Publications by Year

Research Areas

Protease and Inhibitor Mechanisms, Iron Metabolism and Disorders, Hemoglobinopathies and Related Disorders, Blood Coagulation and Thrombosis Mechanisms, Cell Adhesion Molecules Research

Most-Cited Works

→ Iron absorption from oral iron supplements given on consecutive versus alternate days and as single morning doses versus twice-daily split dosing in iron-depleted women: two open-label, randomised controlled trials(2017)407 cited
→ Serum hepcidin: reference ranges and biochemical correlates in the general population(2011)300 cited
High tumor levels of vascular endothelial growth factor predict poor response to systemic therapy in advanced breast cancer.(2001)
→ Correlation of rheumatoid arthritis severity with the genetic functional variants and circulating levels of macrophage migration inhibitory factor(2005)208 cited
→ Immunochemical and Mass-Spectrometry–Based Serum Hepcidin Assays for Iron Metabolism Disorders(2010)196 cited
→ Association between High Levels of Blood Macrophage Migration Inhibitory Factor, Inappropriate Adrenal Response, and Early Death in Patients with Severe Sepsis(2007)108 cited

→ Evaluation of the efficiency of chemotherapy in in vivo orthotopic models of human glioma cells with and without 1p19q deletions and in C6 rat orthotopic allografts serving for the evaluation of surgery combined with chemotherapy(2002)

107 cited

→ A Sensitive and Robust Assay for Urokinase and Tissue-Type Plasminogen Activators (Upa and Tpa) and Their Inhibitor Type I (Pai-1) in Breast Tumor Cytosols(1997)92 cited

→ Toward Worldwide Hepcidin Assay Harmonization: Identification of a Commutable Secondary Reference Material(2016)84 cited

Epidermal growth factor receptor-negative tumors are predominantly confined to the subgroup of estradiol receptor-positive human primary breast cancers.(1991)